Island Pharmaceuticals Limited

A$0.33As of Sun 8 Nov 2026, 12:00 UTC
ASX:ILAHealthcare
Country Australia
PE (Fwd) •••
TSR 6Y CAGR (4.83%)
Div yield —
ROE (95.50%)
Biotechnology
Beta (5Y) 0.13
PE TTM —
TSR TTM (24.42%)
Mkt cap A$96.23M
ROIC (62.67%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.379
16.74%
(49.64%)
Hold 3|7|1|7|5
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
22.60%
28.74%
26.37%
13.63%
Revenue$M
6.212
6.531
6.508
6.546
0.93%
2.93%
5.49%
7.22%
Peers (US$66.09M)
Cap (US$)
PE
84.53M
—
52.58M
—
Capital
TTM
5Y
10Y
Leveragex
2.333
0.886
0.717
EBIT/Intx
0.184
0.136
0.156
Own earn%
272.31
(13.83)
(25.56)
Sh yield%
52.73
40.22
40.08
Owners
Insiders/Inst%
12.16
76.16
Short interest%
0.77
SBC / revenue%
5.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
19–28
$1 testx
4.3
Incr. ROIC%
12